NILVERM POUR-ON

Main information

  • Trade name:
  • COOPERS NILVERM POUR-ON CATTLE WORMER
  • Pharmaceutical form:
  • TOPICAL SOLUTION/SUSPENSION
  • Units in package:
  • 1L,2L,5L,20L
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • INTERVET AUSTRALIA

Documents

Localization

  • Available in:
  • COOPERS NILVERM POUR-ON CATTLE WORMER
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | CATTLE - UNDER 12 MONTHS OF AGE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DA
  • Therapeutic area:
  • anthelmintic
  • Therapeutic indications:
  • BARBER'S POLE WORM - HAEMONCHUS PLACEI | BLACK SCOUR WORM - TRICHOSTRONGYLUS SPP. | HOOKWORM - BUNOSTOMUM SPP. | INTESTINAL THREADWORM-STRONGYLOIDES SPP. | LARGE BOWEL WORM - OESOPHAGOSTOMUM SPP. | LUNGWORM - DICTYOCAULUS SPP. | NODULE WORM - OESOPHAGOSTOMUM SPP. | SMALL BROWN STOMACH WORM-OSTERTAGIA SPP. | SMALL INTESTINAL WORM - COOPERIA SPP. | STOMACH HAIR WORM | THIN NECKED INTESTINAL WORM | HAIR WORM | INTESTINAL HAIR WORM | SMALL HAIR WORM | TELADORSAGIA
  • Product summary:
  • For the treatment of Mature and Immature Roundworms including Lungworm in cattle.Do not treat dogs or horses with this product. Do not use this formulation as an oral drench or as an injection. See Precautions on label also.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 36168/0204
  • Authorization date:
  • 17-08-2004
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

EIII1:III

hllldiing

week,

pl1lglllllt

IIId

young

rinallto

avoid

1IV_'1at1'8s8.

AYDkI

'/IRInD

IIIImalB

off.feed

overJ1WIt,

lIId

ell8Ur8

IIIImalB

8CCe88

W8I8r

....

_eel

IIf10r

drenching.

Recommended

8IIClUId

8IC8edeel,

except

IIIdIrvetertnary

supeMIlon.

........

'III."

Dole

ral8

5ni.

1IIe~

tIbIe

IIIlI'I

used

ANIW.

DOSElntJ

QIT1CAL

COMMENTS

WBGHT(IJg)

bacIcIne

lIIIIng

8IM\CIIII

IIIIlIIIClID.

reconmeJlded

that

bro8d

8Irtpe

appIIcaIIoo

lIbout

75rm1

wide

used.

DONOTuseoralchncNng

other

appIcabs.

lIRE:

1IIe

Ivew8IgIIt

shcdJ

estImII8d

ClI'8fuI'/IO

that

dole

CIII

cabllaled

lImIbIf'I.

.....

1IlIIIWe

IIIInlIIs

8IIClUId

weighed

or a

weight

bini

used

CIIIIIt

_"

.. . . . . . . . . .......... .

1t1mL

.......

ConclmJnt

wtIb

pcu-on

products

requires

IIpII'lIII

appIcaIIon

the bdIIne.

~PERIOD:

I&1'-DOIOT

...............

..........

-..c-~PERIOD"

COOPeRS-

NILVERM-

POUR-ON

CA11II

cu.s

NDEIII

Pou'-Qn

ClIltIe

WOnner

contaInIlMmI8oIe,

menDlrofthe

lIUdIZoINazlAefllllllr

lIId

etIIIclIve

ClItIIe

aoant

INInI8ole-UcePllble

8IrIInI

lIPllcIIS:

MalIn

IIId

IrnmaIln

BIItIef'I

pale

WOI1YI

(1IaImDncIu

Ston8:b

hIIIr

WOI1YI

.. . .

IlIadlllCOlll'

worm

(mctIosIJD'\IIUl\IIP.~

SmalInlaIInI\l

warm,

(QqIiIriI

l\IIP.~

ThIn

nedcId

InlaIInI\l

worm

(AIlrmItd1.Is

l\IIP.),

Hookwunn

l\IIP.),

StroJl(DlokIes,

NoIkM

lIIdl8lgebowilll..-

(~l\IIP.),_

lungworm

(1)>:t)a:arU

l\IIP.),

lIId

malin

only)

SmaI

bnMn

... .. .. .

WOI1YI

(~l\IIP.),

ClItIIe

IIIdIr

1211lO111118

.

When

08tIrIBgIa

probMm

catIIe

CMII'

IIIOI1Ihll

COOPERS

PARAMAP

Pour-on

Beef

lIId

Dalty

C8tIIIt

COOPERS

recormMIfllIed

product.

intimal

pn8IBs

dMlop

resistance

drlInchIB

(1IIthIlm1nUc8).

"dnlnch

(anthelmintic)

falll18

with

this

prlplllIIon

upected,

seek

v8lBmary

conftrmatlon

lIId

naIIfy

1IIIIIUfacturer.

~FOII.

.........

DOIOT

1JNdId,

CIIltIe

III1Jw

temporary

signs

ItImIMan

lIId

frIBIdne88

... .

1118l188d

fnJm

yardI

IOOll

treatment.

delIIl1IIIle

COWl

lIId

heIflIrIlntheyardior

small

paddock

holn_

treatment.

Other

1IIIght8ldHftectl

ofbrt8lCUdon

8UCh

8IIIYItIoIIlIId

IIf1IY8mg

. .. .

tnllIbnenI

rinaIs

which

IA'"

durtng

condIllons.

Som8I111nl11s~lII1Jwwryq

ofllldn

.....,

foIlJIRlg

bI8ImenI

with

t i l

......

11lIII1IIIlUd

COII11ld118d

pertIcliIty

before

tr88Img

shoW

lIId

stud

1IIInlIIs.

ACTIVE

CONSTITUENT:

125g/L

LEVAMISOLE

Solwnt:

373.5g/L

ETHYLENE

GLYCOL

MONOBUTYL

ETHER

ACETATE

treatment

Matu

.. .

Immatu

Roundworms inclvel

. . ..

Lungworm

Cattle

POISON

KEEP

REACH

CHILDREN

READ

SAFETY

DIRECTIONS

BEFORE

OPENING

us.-

FOIl

AIIIW.

TREATIEIf

.LIIlUl

APIIMA

....

1Io.

3lI1fWW204

5c:11m1tPlou;l

A8gIIIBnId

1lIdIlMIlk

5c:11m1tPlou;l

Ull2004

WAIIRMTY

Sdl8ftng-Plough

(SPPL)

WIfI'lIrIB

th8t

thll

product

rnetchantable

quality

III1d

Itslntlnded

1IUfJIOII8.

SPPI.

IIaIJIIIty

1oB8,IncIldng

consequentIIIlo8I8s

i$IIJ

caused

omIBsIon,

including

negligent

aclB

omI88IonI

SPPl.

agent

III1m1t8d

\1lIIIlI*1Il

I'IIJIIRIll

pnxIucI

opIIon

SPPL."

poasIbIe,

pnIduc:t

causing

concern

8IIClUId

r8IIIned

deII¥\nId

SPPl

within

days

acientIftc

8XlIRIInlIIIon.

DI&POUL

1I1pta

(p\'8fenIbIy)

1I'8I8Ur8

rtnse

containers.

notdlBpose

undiluted

cIwnIcaIs

on-lIIte.

A8Un

clean

container

rqdlng

where

thll II

opIIon

cII8poBaI

landfill

lIIdhorI8ed

acceptth8t

WBBte.

"

. .. .

th88e

options

lMIIIIIbIe,

IIUIy

cmtaIner

below

500nIn

dIlIpo8al

spedftcally

IIIlIUd

lIId

setup

thlllIUfJIOII8

clear

waI8I

ways,

vegetallon

lIId

rooIJ.

Empty

contBInell

stIould

lulled.

CUnI8

1IiIIIcIIId1U

...........

0IIIIIIcIan

STORME

StIn

below

3O"C

(Room

TemperaIure)

cUed,

ortgIR8I

conl8Iner

WIll

ventIIaIed

area.

ItDntfor

prolonged

plIItodB

direct

lItIlIIghL

SPECWJST

ADVICE.

-..cy_y

SCher1ng-PIotd1

1._511

....

-AUSIMI.IA

WIDE

COOPeRS-

NILVERM

POUR-ON

CA11II

WOIMII

GennlInIb

....

After

use,

clean

lIIlPIICatOr

WIIllhIng

through

wtIb

.. .. .

W8I8r

conIBInIng

d8t1rgent

followed

dean

cddwater.

....

.............

CDapnCUllll.-

SInIllI

1.228511.

SAFETY

DIIIECTIc.

TbII

IIdn

....

_1inIIII&..,

1Ii'rIIIIt

.....

.............

IMIII

.........

.......

......

_CIIIlIn

IIIlIIDnIlIIU

. . . .. .

.....

......

IIlIIIIL

lIIId

.............................

......,

. .. ......... .. .. ... . .. .

. .. .

............

IIIIIn

drtnIdIII-

..........................

........,

...........................

.............................

.....

FIRST

.........................

docIDr

.....

... ... . . ..

ClnhlPlaw13112J1t,.-

. . ..

.....................................

_1IIonIugIIIr."

1IDId

ilooii

...........

1&

dDIlIDr,

AddIIIonaIInI'ol.Ii8IIon

II lilted

Mat8fIaI

sarety

DalaShllt.

>

(jt"""::g>

o>;;o'i:l

-----------

----------------------------~------~--------------

t:l:i'

<

----l

~m<3:'

t"""m>

Info

pest

Verified

17-12-2018

Michigan-based food manufacturer agrees to stop operations after repeated food safety violations

Michigan-based food manufacturer agrees to stop operations after repeated food safety violations

Saranac Brand Foods, Inc. specialized in a variety of 35 different ready-to-eat foods, including prepared salads, dips, and sauces.

FDA - U.S. Food and Drug Administration

14-12-2018

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Published on: Thu, 13 Dec 2018 The European Commission asked EFSA for a scientific evaluation on the risks to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food. Regarding PFOS and PFOA occurrence, the final data set available for dietary exposure assessment contained a total of 20,019 analytical results (PFOS n = 10,191 and PFOA n = 9,828). There were large differences between upper and lower bound exposure due to analytical methods with i...

Europe - EFSA - European Food Safety Authority Publications

29-11-2018

Glyphosate: ANSES launches a comparative assessment with the available alternatives

Glyphosate: ANSES launches a comparative assessment with the available alternatives

Following the five-year re-approval of this active substance at European level in December 2017, ANSES is reassessing marketing authorisations for products containing glyphosate. For products for which an application for authorisation or re-authorisation has been submitted, the Agency will carry out a comparative assessment with the available alternatives. For each glyphosate-based product, all uses for which there is an alternative that meets the substitution criteria will therefore be prohibited.

France - Agence Nationale du Médicament Vétérinaire

21-11-2018

VaperBC recalls 100 mg Nicotine Base Liquid Nicotine

VaperBC recalls 100 mg Nicotine Base Liquid Nicotine

These vaping products do not meet requirements of the Consumer Chemicals and Containers Regulations, 2001 (CCCR, 2001) under the Canada Consumer Product Safety Act.

Health Canada

21-11-2018

Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food

Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food

Published on: Tue, 20 Nov 2018 The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of dioxins (PCDD/Fs) and DL‐PCBs in feed and food. The data from experimental animal and epidemiological studies were reviewed and it was decided to base the human risk assessment on effects observed in humans and to use animal data as supportive evidence. The critical effect was on semen quality, following pre‐ and postnatal exposure. The critical s...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

Registration Reminder: FDA Center for Veterinary Medicine Public Webinar about Genome Editing in Animals on Dec. 3

Registration Reminder: FDA Center for Veterinary Medicine Public Webinar about Genome Editing in Animals on Dec. 3

On Dec. 3, 2018, FDA’s Center for Veterinary Medicine (CVM) will hold a public webinar about genome editing in animals, focusing mainly on current scientific evidence, promising uses of this technology in animals, the potential risks & CVM’s flexible, risk-based approach to regulation.

FDA - U.S. Food and Drug Administration

9-11-2018

First Choice Vapor recalls Unflavoured 100 mg Nicotine Base E-Liquids

First Choice Vapor recalls Unflavoured 100 mg Nicotine Base E-Liquids

These vaping products do not meet requirements of the Consumer Chemicals and Containers Regulations, 2001 (CCCR, 2001) under the Canada Consumer Product Safety Act.

Health Canada

1-11-2018

Publiekscampagne Ik Zorg van start

Publiekscampagne Ik Zorg van start

Vandaag gaven minister Hugo de Jonge, minister Bruno Bruins en staatssecretaris Paul Blokhuis het startsein voor de publiekscampagne Ik Zorg. Hiermee willen de sector Zorg en Welzijn en de overheid nieuwe werknemers aantrekken. Dat is hard nodig, om ook in de toekomst iedereen goede zorg te kunnen blijven bieden. Als we nu niks doen, hebben we in 2022 een tekort van 125.000 mensen.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

23-10-2018

Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer

Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer

A federal court orders a Tennessee-based company to stop selling over-the-counter (OTC) drug products

FDA - U.S. Food and Drug Administration

18-10-2018

Ryerson Canada and Vista Railings Systems Inc. recall Various ProBuilt Aluminum Deck Railing Posts

Ryerson Canada and Vista Railings Systems Inc. recall Various ProBuilt Aluminum Deck Railing Posts

Certain ProBuilt Aluminum Posts have an issue with the screws that affix the base plate to the post which may cause the post to separate from the base plate when forces over 334 pounds are applied horizontally to the top side of the post. As a result, the posts do not fully comply with local building code requirements and may pose a fall hazard.

Health Canada

28-9-2018

FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

FDA - U.S. Food and Drug Administration

27-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

FDA issues a request for information to solicit feedback on how consumers are using plant-based substitutes for milk, cheese and other dairy foods.

FDA - U.S. Food and Drug Administration

22-9-2018

Risk assessment of new sequencing information on genetically modified carnation FLO‐40689‐6

Risk assessment of new sequencing information on genetically modified carnation FLO‐40689‐6

Published on: Fri, 21 Sep 2018 00:00:00 +0200 The GMO Panel has previously assessed genetically modified (GM) carnation FLO‐40689‐6 and concluded that there is no scientific reason to consider that the import, distribution and retailing in the EU of carnation FLO‐40689‐6 cut flowers for ornamental use will cause any adverse effects on human health or the environment. On 27 October 2017, the European Commission requested EFSA to analyse new nucleic acid sequencing data and updated bioinformatics data for...

Europe - EFSA - European Food Safety Authority Publications

16-8-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans

FDA announces workshop on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans.

FDA - U.S. Food and Drug Administration

10-8-2018

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and often fatal genetic disease and the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.

FDA - U.S. Food and Drug Administration

9-8-2018

Vita-Mix Corporation recalls Ascent and Venturist Series 8-ounce and 20-ounce Blending Containers

Vita-Mix Corporation recalls Ascent and Venturist Series 8-ounce and 20-ounce Blending Containers

The container can separate from the blade base exposing the blades, posing a laceration hazard to consumers.

Health Canada

7-8-2018

Seaweed consumption: remain vigilant to the risk of excess iodine intake

Seaweed consumption: remain vigilant to the risk of excess iodine intake

Over the last few years, seaweed has become increasingly common on our plates. Fresh, dried or as a food supplement, its iodine content varies and can sometimes be high. ANSES assessed the risk of excess iodine intake from the consumption of seaweed-based products. In view of the non-negligible risk of exceeding the upper limit of safe intake for iodine, the Agency advises against the consumption of seaweed and seaweed-based food supplements by certain at-risk populations, and recommends that regular con...

France - Agence Nationale du Médicament Vétérinaire

13-7-2018

Water Pik, Inc. Recalls Sonic-Fusion® Flossing Toothbrush Product for Possible Health Risk

Water Pik, Inc. Recalls Sonic-Fusion® Flossing Toothbrush Product for Possible Health Risk

Water Pik, Inc. is voluntarily recalling its Sonic-Fusion® flossing toothbrush because the charging base may overheat with localized melting and sparking, possibly causing fire, shock or burns. Water Pik, Inc. has received consumer reports of product malfunctioning in the U.S. The recall is applicable only to Sonic-Fusion® products. All other Waterpik® brand flossers and toothbrushes are not affected.

FDA - U.S. Food and Drug Administration

28-6-2018

Minister Bruno Bruins verbetert transparantie zorgverzekeringen

Minister Bruno Bruins verbetert transparantie zorgverzekeringen

Er zijn in Nederland 55 verschillende standaard basisverzekeringen. In de praktijk worden verzekeringen onder allerlei namen en in verschillende verpakkingen aangeboden. Een van de verpakkingsvormen zijn de ongeveer 51.000 verschillende collectieve zorgverzekeringen. Hierdoor is de zorgverzekeringsmarkt ondoorzichtig geworden en is goed vergelijken een haast onmogelijke opgave. Minister Bruno Bruins (Medische Zorg) wil daarom dat zorgverzekeraars zorgen voor meer transparantie, onder andere door precies ...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

21-6-2018

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

NOW Health Group, Inc. (NOW), of Bloomingdale, Illinois, is recalling its NOW Real Food® Zesty Sprouting Mix – Product Code 7271, Lot #3031259 and Lot #3038165 – because its primary ingredient, Crimson Clover Seeds, has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may b...

FDA - U.S. Food and Drug Administration

14-6-2018

FDA Releases FSMA Draft Guidance on the Supply-Chain Program Preventive Control for Animal Food

FDA Releases FSMA Draft Guidance on the Supply-Chain Program Preventive Control for Animal Food

FDA issued draft guidance to help animal food facilities needing a supply-chain program meet those requirements under the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals rule.

FDA - U.S. Food and Drug Administration

12-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

FDA - U.S. Food and Drug Administration

3-5-2018

FDA Approves Application for AquaBounty Salmon Facility in Indiana

FDA Approves Application for AquaBounty Salmon Facility in Indiana

FDA approved a supplemental New Animal Drug Application submitted by AquaBounty Technologies, Inc. The supplemental NADA requested FDA approval to raise AquAdvantage Salmon at a land-based contained facility near Albany, Indiana.

FDA - U.S. Food and Drug Administration

2-12-2018

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies to advance these efforts pic.twitter.com/2co2Hz4jUt

FDA - U.S. Food and Drug Administration

30-10-2018

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Active substance: Phosphorothioate oligonucleotide targeted to transthyretin) - Transfer of orphan designation - Commission Decision (2018)7282 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/098/13/T/01

Europe -DG Health and Food Safety

30-10-2018

EU/3/18/2071 (Loxo Oncology Limited)

EU/3/18/2071 (Loxo Oncology Limited)

EU/3/18/2071 (Active substance: 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile) - Orphan designation - Commission Decision (2018)7272 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/125/18

Europe -DG Health and Food Safety

29-6-2018

EU/3/18/2033 (Real Regulatory Limited)

EU/3/18/2033 (Real Regulatory Limited)

EU/3/18/2033 (Active substance: Codon-optimised human ornithine transcarbamylase mRNA complexed with lipid-based nanoparticles) - Orphan designation - Commission Decision (2018)4178 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/022/18

Europe -DG Health and Food Safety

15-6-2018

Comparable overseas regulators (CORs) for prescription medicines

Comparable overseas regulators (CORs) for prescription medicines

Minor clarifications to the prescription medicines COR report-based process and the list of CORs for work-sharing.

Therapeutic Goods Administration - Australia

28-5-2018

Seresto and its associated name Foresto

Seresto and its associated name Foresto

Seresto and its associated name Foresto (Active substance: imidacloprid/flumethrin) - Community Referrals - Art 13 - Commission Decision (2018)3404 of Mon, 28 May 2018 European Medicines Agency (EMA) procedure number: EMEA/V/A/125

Europe -DG Health and Food Safety

18-5-2018

EU/3/14/1252 (Chiesi Farmaceutici S.p.A.)

EU/3/14/1252 (Chiesi Farmaceutici S.p.A.)

EU/3/14/1252 (Active substance: Cysteamine bitartrate) - Transfer of orphan designation - Commission Decision (2018)3133 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/164/13/T/01

Europe -DG Health and Food Safety

18-5-2018

EU/3/14/1383 (IQVIA RDS Ireland Limited)

EU/3/14/1383 (IQVIA RDS Ireland Limited)

EU/3/14/1383 (Active substance: Single-chain urokinase plasminogen activator) - Transfer of orphan designation - Commission Decision (2018)3150 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/125/14/T/01

Europe -DG Health and Food Safety